Medtronic Announces CE Mark of Viva/Brava Cardiac Resynchronization Therapy Devices
18:05 EDT 20 Aug 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
New Devices Automatically Adapt to Patient Needs and Continuously Optimize CRT, Improving Response Rate to Lifesaving Therapy MINNEAPOLIS - August 20, 2012 - Medtronic, Inc. today announced it has received CE (Conformité Européenne) Mark of its ...
Other Sources for this Article
More From BioPortfolio on "Medtronic Announces CE Mark of Viva/Brava Cardiac Resynchronization Therapy Devices"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
